Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer

Affiliations

¹ Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY.
² Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY kunle.odunsi@roswellpark.org.

Editorial

Emese Zsiros et al. J Clin Oncol. 2015.

. 2015 May 10;33(14):1521-2.

doi: 10.1200/JCO.2014.60.6566. Epub 2015 Apr 6.

¹ Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY.
² Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY kunle.odunsi@roswellpark.org.

No abstract available

Comment on

Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.
Stevanović S, Draper LM, Langhan MM, Campbell TE, Kwong ML, Wunderlich JR, Dudley ME, Yang JC, Sherry RM, Kammula US, Restifo NP, Rosenberg SA, Hinrichs CS. Stevanović S, et al. J Clin Oncol. 2015 May 10;33(14):1543-50. doi: 10.1200/JCO.2014.58.9093. Epub 2015 Mar 30. J Clin Oncol. 2015. PMID: 25823737 Free PMC article.